GSK, Pfiz­er con­tra­dict on the fu­ture of con­sumer health JV — re­port

It ap­pears GSK and Pfiz­er — who run a con­sumer health JV to­geth­er — for­got to get their sto­ry straight ahead of this year’s JP Mor­gan con­fer­ence.

On Tues­day, Pfiz­er chief Al­bert Bourla said he ex­pect­ed the JV’s ma­jor­i­ty own­er GSK to work to­ward an IPO with­in three to four years.

The fol­low­ing day, GSK’s chief strat­e­gy of­fi­cer David Red­fern told Bloomberg that the con­sumer busi­ness needs to in­te­grate and grow and that an IPO wasn’t the on­ly vi­able op­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER